Related by context. All words. (Click for frequent words.) 81 leading lipid nanoparticle 71 RNA interference RNAi therapeutics 70 SNALP 70 commercializing anti infective 70 stable nucleic acid 70 DiLA2 70 immunotherapeutics 70 Kosan dependence 70 proprietary PEGylation 69 systemic RNAi 68 NovaBay Aganocide compounds 68 rxRNA 68 Adnectin 68 Tekmira SNALP 68 siRNA therapeutics 68 novel therapeutic antibodies 68 ALN PCS 68 monoclonal antibody therapeutics 67 Selective Electrochemical Tumor Ablation 67 novel anti infective 67 novel antibody therapeutics 67 RNAi therapeutic targeting 67 antisense drugs 67 Locked Nucleic Acid 67 DPX Survivac 67 Nasdaq HALO biopharmaceutical 67 proprietary Biochronomer 67 molecular imaging radiopharmaceutical 67 Provectus Pharmaceuticals specializes 67 RNAi therapeutic 67 lead molecular radiotherapeutic 67 humanized monoclonal antibodies 67 Enhanze TM Technology 67 NuMimetic TM 67 LentiVector technology 67 novel antiviral therapeutics 67 Dicer Substrate Technology 67 Liprotamase 67 enhanced skin permeation 67 Novosom 67 ArQule Kinase Inhibitor 66 Cobalamin TM mediated 66 candidates Azedra TM 66 therapeutic monoclonal antibodies 66 lipid particles SNALP 66 DURECT proprietary 66 KL4 surfactant 66 oral transdermal 66 NTDDS 66 mediate RNAi 66 MDRNA proprietary 66 therapeutic monoclonal antibody 66 liposomal delivery 66 isoform selective 66 ArQule Kinase Inhibitor Platform 66 candidate deforolimus 66 microRNA therapeutics 66 novel peptides 66 proprietary buccal 66 commercializing therapeutic 66 Captisol ® 66 molecular chaperone regulation 66 Dyax phage display 66 Inc. AMEX YMI 66 Inc. Nasdaq ALNY 66 product platforms AZX# 66 ddRNAi 66 Amgen discovers develops 66 CCR9 antagonist 66 ALN TTR 66 RONDEL ™ 66 targeting PCSK9 66 Tekmira SNALP technology 66 proprietary transdermal 66 Bioral 66 kidney urologic 66 PNP inhibitor 66 gastro intestinal inflammation 66 proprietary polysaccharide 66 Amgen discovers develops manufactures 66 oncolytic virus therapies 66 HepDirect R 66 RNA antagonists 65 FOLOTYN ® 65 Nasdaq LXRX biopharmaceutical 65 THR beta agonist 65 lipid nanoparticle 65 biochemical profiling 65 Nasdaq IDIX biopharmaceutical 65 LNP formulations 65 oral prodrug 65 candidates Azedra 65 CYT# potent vascular disrupting 65 subsidiaries visit http:/www.apricusbio.com 65 CobaCyte 65 commercializes therapeutics 65 AKIP ™ 65 systemic RNA interference 65 RNAi therapeutics 65 pharmacological chaperone 65 miRNA therapeutics 65 anti infective treatments 65 AAG geldanamycin analog 65 ZFP Therapeutics 65 Applied NeuroSolutions 65 transthyretin mediated amyloidosis ATTR 65 recombinant biopharmaceutical 65 ALN TTR# 65 ASONEP TM 65 PEGylation technology 65 theranostic 65 MSCRAMM ® 65 acetonide FA 65 GVAX ® 65 polymer conjugate technology 65 topically delivered 65 www.ucb group.com 65 POTELLIGENT R 65 virus AAV 65 targeted radiotherapeutic 65 Aganocide ® 65 delivered RNAi therapeutic 65 siRNA therapeutic 65 Pentad TM 65 romazarit 65 POTELLIGENT ® 65 rusalatide acetate 65 Fleximer R 65 Solazed TM 64 Zemiva TM 64 Personalized Immunotherapy 64 AtuRNAi 64 Tumour Vascular Disrupting Agent 64 anticancer therapeutics 64 Nasdaq MNKD focused 64 Nektar proprietary 64 Nanobody R 64 Alnylam #x# 64 programs visit http:/www.bionovo.com 64 cosmetic cosmeceutical products 64 ChromoCure develops 64 developing TB4 64 selective kinase inhibitors 64 ALTROPANE R 64 StromaCel Inc. 64 NS5b 64 monocytogenes Listeria vaccines 64 peptide peptide mimetic 64 Sangamo ZFP technology 64 AtuPLEX 64 include Altastaph TM 64 ALN HTT 64 HuMax TAC 64 antiangiogenesis therapies 64 Neogenix 64 antibody fragment therapeutics 64 targeted immunotherapies 64 acne impetigo 64 ALN VSP 64 small molecule PEGylation 64 IMiDs R 64 ASG 5ME 64 superior bioprocessing 64 Bioral R 64 oncolytic 64 patented Bioral 64 Targeted Chemotherapy 64 proprietary NexACT ® 64 immunotherapeutic approaches 64 antagomirs 64 endosomal release 64 Inc. NASDAQ IDMI 64 JAK1 64 rxRNA TM compounds 64 P#X# antagonist 64 human antibody therapeutics 64 intranasal vaccines derived 64 purinergic receptors P#X# 64 technology visit http:/www.genmab.com 64 Endotis 64 Cyclosert TM 64 Etubics 64 PharmFilm ® 64 aptamer therapeutics 64 selective angiogenic kinase inhibitor 64 CysDisplay R 64 targeted anticancer biopharmaceuticals 64 rxRNA ™ compounds 64 Salmonella vector 64 pralatrexate injection folate analogue 64 rxRNA compounds 64 adrenergic regulation 64 platform HDL Mimetic 64 Tekmira lipid nanoparticle 64 engineered proteases 64 SNALP technology 64 Chimigen TM 64 DsiRNA 64 Alnylam RNAi 64 microRNA antagonists 64 Prodarsan R 64 Nasdaq ALNY 64 5 HT3 antagonist 63 clinically validated targets 63 Stapled Peptide 63 Epitomics 63 AN# novel 63 staphylococcal vaccines 63 novel immunotherapies 63 vaccines oncolytic virus 63 PharmFilm R 63 OTCBB URGP specialty 63 molecular therapeutics immunotherapies 63 novel immunomodulatory 63 oral dihydropyrimidine dehydrogenase DPD 63 immuno inflammatory diseases 63 Bioral ® 63 molecular imaging radiopharmaceuticals 63 NovaDel oral spray 63 OTCBB QTXB 63 SPL# Gel vaginal microbicide 63 patented NanoStat ™ 63 Isis antisense 63 SMaRT ™ 63 DOS# 63 Nanobody 63 innovative signaling pathway 63 topical anti infective 63 Transdel TM 63 COMPLEGENT TM Technologies 63 small molecule agonists 63 Initiates Phase II 63 commercialize deforolimus 63 infectious diseases autoimmune diseases 63 AzaSite Xtra 63 PROfusion 63 Combivir Kivexa 63 Locked Nucleic Acid LNA 63 subsidiary Cira Biosciences 63 LHRH antagonists 63 4SC AG ISIN DE# 63 short interfering RNA 63 targeting CD# 63 PDE4 modulators 63 commercializing novel biotherapeutics 63 TIMERx 63 proprietary dermal 63 proprietary capillary aerosolization 63 personalized cellular immunotherapy 63 Inc. OTCBB APNS 63 patented NanoStat TM 63 OTCBB INSV 63 overactive bladder VANTAS R 63 HepDirect 63 TRACON Pharmaceuticals 63 Ibis T# TM 63 dermatology therapies 63 tiapamil 63 recombinant adeno associated 63 TRANSDUR ® 63 Iluvien ® 63 commercial bioproduction 63 MKC# MKC# PP 63 target Galectin receptors 63 CDK cyclin dependent 63 XL# XL# 63 RNAi therapeutic platform 63 neuro inflammatory disorders 63 small molecule therapeutics 63 Aganocide TM 63 Intermezzo ® zolpidem tartrate 63 Sphingomab TM 63 novel peptide 63 NurOwn 63 topical dermatology 63 encapsulates siRNAs 63 BioWa 63 KL4 Surfactant 63 immunologic diseases 63 MTP inhibitor 63 cyclophilin inhibitors 63 Hybridon 63 liver cancers hypercholesterolemia 63 JAK2 inhibitor 63 Therapeutic Competitors Companies 63 DiLA2 Platform 63 proprietary liposomal 63 Panzem R 63 Fleximer 63 cellular immunotherapy 63 MediVas 63 Oracea TM 63 proprietary MSCRAMM ® 63 mucosal vaccines 63 intranasal insulin product 63 tests miRview TM 63 Aganocide 63 Genasense evaluating 63 ABL inhibitor 63 anionic backbone 63 Homspera TM 63 biotherapeutic drugs 63 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 63 Alfacell proprietary ribonuclease 63 TRIOLEX HE# APOPTONE HE# 63 targeted anticancer therapies 63 ophthalmic therapeutics 63 AKIP 63 ATRA IV 62 Ii protein 62 platinum chemotherapeutic 62 delivery polymer matrix 62 Squalamine 62 PORxin TM 62 psoriasis rheumatoid arthritis 62 HCV NS3 protease 62 CYT# novel 62 buccal delivery 62 Curaxins 62 oncolytic viruses 62 biodefense vaccines 62 selective kinase inhibitor 62 small molecule thrombopoietin 62 novel therapeutics 62 cancer immunotherapies 62 sirtuin therapeutics 62 Company TAIFUN R 62 proven DuraSite ® 62 SGLT Inhibitors 62 proprietary biomaterials 62 including Cobalamin TM 62 Dyax logo 62 Angiocept 62 proprietary Dicer Substrate Technology 62 DiLA 2 62 clinically differentiated 62 Anticalin 62 commercialize Aganocides 62 ELADUR ™ 62 peptide therapeutics 62 RONDEL TM 62 HuCAL GOLD R 62 novel VDA molecule 62 TOCOSOL 62 CAMBRIDGE Mass. Alnylam Pharmaceuticals 62 diseases fat malabsorption 62 Cardium Therapeutics TM 62 plasmid DNA pDNA 62 Eligen ® Technology 62 Restoraderm 62 TIMERx R 62 LentiVector 62 XmAb ® 62 Nicotine Conjugate Vaccine 62 oral ghrelin agonist 62 Celator 62 ADCC enhanced 62 delivers fluocinolone acetonide FA 62 DepoVax ™ 62 IntraOp Medical Corporation 62 Cobalamin TM 62 systemic RNAi therapeutic 62 Opterone R 62 PI3K/Akt pathway inhibitor 62 dihydrochloride Tablets 62 therapeutic peptide 62 influenza hypercholesterolemia 62 identify protein biomarkers 62 RNAi compounds 62 Nasdaq IDRA 62 http:/www.generex.com 62 proprietary NexACT drug 62 selectively inhibit replication 62 proprietary bioresorbable polymer 62 Brussels THR 62 IMiDs ® 62 About Positron Positron 62 NYSE Amex RNN 62 SuperAntibody 62 Investigational eFlow Nebulizer System 62 Nasdaq RXII 62 discovery anddevelopment 62 cardio metabolic diseases 62 Nasdaq ENZN 62 adrenal steroid hormones 62 Onalta TM 62 VitiGam 62 novel proprietary KL4 62 Vitrasert ® 62 Vitrasert R 62 peptides proteins 62 Foradil Aerolizer 62 Eg5 kinesin spindle 62 catalytic antioxidant compounds 62 DNA methyltransferase inhibitors 62 OTCBB TDLP 62 oncology therapeutics 62 Nanobody ® 62 Profectus BioSciences 62 biased ligand 62 proprietary DuraSite ® 62 Board LWLG technology 62 Bioral Amphotericin B. 62 Aradigm Logo 62 Intravenous Human 62 synthetic retinoid 62 taste modulators 62 DepoVax ™ vaccine 62 Antigen Express website 62 polysaccharide polymer 62 detection reagents 62 flavors flavor enhancers 62 histone deacetylase HDAC 62 HGS ETR1 mapatumumab 62 Maxy G# 62 neovascular diseases 62 Fibrocell Science 62 Potelligent Technology 62 OTCBB PYTO 62 AVEO Pharmaceuticals NASDAQ 62 liposomal formulation 62 visit www.genenews.com 62 comprise Alnylam RNAi 62 antisense drug 62 IAP inhibitors 62 UltiMAb ® 62 ZaBeCor 62 visit www.genmab.com 62 OTCBB HXBM developer 62 fungal infections malaria tuberculosis 62 LNPs 62 introduced NEUGENE 62 motexafin gadolinium Injection 62 DiscoveRx 62 using ImmunoGen TAP 62 M2 subunit 62 proprietary BiTE R 62 anticoagulant reversing agent 62 Helix BioMedix Inc. 62 CD# CEA 62 XSSE OXGN 62 investigational humanized monoclonal antibody 62 GTC NASDAQ GTCB 62 Xcytrin R 62 aerosolized AAT 62 leading oral taxane 62 mda 7 62 UltiMAb 62 prostone 62 EyeGate Pharma 62 modified glutathione analog 62 Lipid Polymer Micelle LPM 62 DepoVax TM 62 immunotherapies 2A/Furin 62 recurrent metastatic ovarian cancer 62 vivo electroporation 62 Crofelemer budesonide foam 62 Medarex logo 62 Epeius Biotechnologies Corporation 61 Zemiva TM Trofex TM 61 R MSCRAMM 61 signal averaging electrocardiography 61 Alnylam Biotherapeutics 61 Locteron combines 61 Inc. OTCBB ECTE 61 proprietary intranasal insulin 61 Corp. www.anavex.com 61 inhibit metastasis 61 therapeutic peptides 61 technology PolyActive ® 61 theranostics 61 proprietary BiTE ® 61 granisetron formulated 61 vinca alkaloid 61 developing Zerenex TM 61 antiviral therapeutics 61 prophylactic vaccines 61 RNAi Therapeutics 61 HTS assay 61 IMiDs ® compound 61 CYCLOSET ® 61 OTCBB NVLT biopharmaceutical 61 SCIB1 61 sapacitabine CYC# 61 MKC# MT 61 NASDAQ ALTH biopharmaceutical 61 acquires researches develops 61 drug conjugate ADC 61 Selzentry Celsentri 61 BHT DNA 61 OTCQB CTIX 61 Cyclosert 61 therapeutic anticancer 61 JAK inhibitors 61 Prestara TM 61 HuLuc# 61 Pharma Merck Serono 61 investigational monoclonal antibody 61 patented DepoVax ™ 61 5 lipoxygenase activating 61 NYSE Amex PBTH 61 2 inhibitor CYT# 61 phenylketonuria PKU developed 61 HepeX B TM 61 peptibody 61 selective androgen receptor modulators 61 Nasdaq IMGN 61 Adenosine Therapeutics 61 GVAX cancer 61 biologic therapeutics 61 Novelos Therapeutics Inc. 61 Galenea 61 hepatitis C lupus 61 multi kinase inhibitor 61 GSK Rare Diseases 61 TTR amyloidosis 61 Quark Biotech Inc. 61 Soliris eculizumab 61 Cetrorelix 61 non nucleoside inhibitor 61 Alnylam Pharmaceuticals Nasdaq ALNY 61 Abiraterone acetate 61 commercializes innovative 61 compound perifosine 61 CEQ# 61 manufactures minimally invasive 61 LNA TM 61 progressive metastatic prostate 61 nucleoside tide analogs 61 SMARTICLES ® 61 JAK2 Inhibitor 61 Cerashield 61 Chimigen 61 A3 adenosine receptor 61 FORMA Therapeutics 61 renin inhibition promising 61 apricitabine ATC 61 relapsed leukemia 61 XmAb ™ 61 NASDAQ PPHM clinical 61 TKM PLK1 61 developing Surfactant Replacement 61 AVAX AC Vaccine 61 external counterpulsation systems 61 Nanobodies R 61 novel L DOS# 61 OTCQB ABPI 61 AMEX ISV 61 RECOTHROM ® 61 pharmacogenomic translational research 61 NicVAX TM 61 PORxin TM platforms 61 Resurgex Plus R 61 drug conjugate 61 Aradigm Corporation 61 candidate XP# 61 DiLA2 platform 61 lipid nanoparticles 61 OTCBB IMNR 61 VaxImmune 61 OTCBB OHRP 61 Inc. Nasdaq INFI 61 Cobalamin 61 siRNA delivery 61 virology therapeutics 61 PEGylation 61 Pyridorin 61 Sphingomab 61 SinuNase TM 61 liposome formulations 61 delta gamma agonist 61 HuCNS SC ® 61 RNA therapeutics 61 AltheaDx 61 Epothilones 61 TRAIL receptor antibodies 61 HCV protease inhibitor 61 NEUGENE R 61 HCV protease inhibitors 61 HuCAL PLATINUM ® CysDisplay 61 XmAb TM 61 ASX ANX 61 Poly ICLC 61 hypercholesterolemia liver 61 GelSite polymer 61 TESARO 61 OGeS 61 BEMA ® 61 NASDAQ OPXA 61 injectable depot 61 Idera Pharmaceuticals 61 Amir Avniel 61 infectious diseases autoimmune 61 TRANSDUR ™ 61 Veronate R 61 Familial Adenomatous Polyposis FAP 61 Altera Nebulizer System 61 visit http:/www.mannkindcorp.com 61 optical biosensors 61 Aviptadil 61 CRMD pharmaceutical 61 Fibrin MB 61 Kosan epothilone program 61 please visit http:/www.vandapharma.com 61 methylnaltrexone bromide 61 EHT AGN 61 histone deacetylase HDAC inhibitors 61 Archexin 61 YM AIM YMBA 61 Zalypsis 61 fibrosis IPF 61 attach auristatin 61 Azedra 61 NYSE Amex AEN 61 OxBC 61 Nasdaq VRTX 61 Restoraderm R technology 61 Regulus Therapeutics 61 ZFN TM 61 Valortim TM 61 Pruvel TM 61 UltiMAb TM 61 proliferative diseases 61 GlaxoSmithKline MedImmune 61 autologous cellular therapy 61 Inc Therapeutic Competitors 61 orally administered inhibitor 61 ATD TM gel 61 muco adhesive technology 61 Vaccinex 61 AKIP TM 61 Septin9 biomarker 61 commercialize microRNA 61 R Saizen R 61 OMP #R# 61 Synerx Pharma 61 Tarmogen 61 cytotoxic proteins 61 patented DepoVax TM 61 molecular biomarkers 61 HDL Mimetic Peptide 61 commercialize Dimebon 61 doxorubicin Transdrug R 61 vitreoretinal disorders 61 regenerative therapeutics 61 candidate NGX 61 please visit www.medicinova.com 60 LEX System 60 chemically modified siRNA 60 NYSE Amex PTN 60 accumulate preferentially 60 platforms GVAX 60 Surfactant Replacement Therapies SRT 60 Affilin ® 60 Avian Transgenic Technology 60 non porcine pancreatic 60 Trofex TM 60 treat male hypogonadism 60 Generx TM 60 Surfaxin LS 60 commercialize conjugates consisting 60 AAV vectors 60 Sangamo ZFP TF 60 NPC 1C 60 M# rationally 60 XL# anticancer compounds 60 EndoTAG TM 60 Neoprobe subsidiary Cira 60 R sorafenib tablets 60 punctal plug drug 60 proprietary GelSite ® 60 sapropterin dihydrochloride 60 Initiates Dosing 60 Kleanthis G. Xanthopoulos Ph.D. 60 developing ostarine selective 60 Presents Preclinical Data 60 Crucell NV NYSE Euronext 60 oral taxane 60 Potelligent 60 peg EPO 60 sd rxRNA ™ 60 test visit www.radient 60 nano particle tumor suppressor 60 IMiDs 60 Nasdaq RGDX 60 visit http:/www.PAREXEL.com 60 TLR9 agonists 60 tests miRview ™ 60 active AKT inhibitor 60 adipose stem 60 Nasdaq XTLB 60 neurology immunology 60 Agios Pharmaceuticals 60 Regado 60 IMPDH inhibitor 60 protein therapeutics 60 MP4 molecule 60 Aerosurf 60 Pruvel ™ 60 MorphoSys Galapagos 60 Innovive Pharmaceuticals 60 EyeGate ® II 60 PolyActive ® 60 neuro inflammatory 60 protein receptors lectins 60 RNAi compounds rxRNA 60 HDL Therapy 60 Lipocine 60 InterfeRx TM 60 collaborative Product Lifecycle 60 MT#/MEDI-# 60 Onalta 60 Nasdaq IDRA today 60 Receptors GPCRs 60 lipid nanoparticle LNP 60 QUALCOMM Incorporated http:/www.qualcomm.com 60 Initiates Enrollment 60 commercializing aptamer therapeutics 60 targeting Inflammatory Bowel 60 siRNA compounds 60 TSX YM AIM 60 Nasdaq PARD 60 metaglidasen 60 Nasdaq IDRA biotechnology 60 candidate Zemiva 60 PNT# 60 NexACT ® 60 Pain Neutralizer holds 60 advanced polymer conjugate 60 developing topically administered 60 treat refractory angina 60 Company Nasdaq RGDX 60 humanized anti 60 commercializing oxidized glutathione 60 MEDAREX 60 Reports Preclinical Data 60 Receptos 60 Staphylococcus aureus Immune Globulin 60 IMA# 60 URG# 60 exon skipping 60 include PLX IBD 60 IAP inhibitor 60 MyVax R 60 JAK3 60 Micromet proprietary BiTE 60 delipidation 60 oral salmon calcitonin 60 InterfeRx 60 SECTA therapy 60 Currently RegeneRx 60 mertansine 60 Alzheimer disease cognitive impairment 60 Exelixis compounds 60 investigational compounds 60 Naglazyme R 60 Peyronie disease Frozen Shoulder 60 Perflubutane Polymer Microspheres 60 regarding Aethlon Medical 60 NASDAQ CRXL 60 Merrimack Pharmaceuticals 60 BioFocus DPI Galapagos 60 website www.lipidsciences.com 60 Listeria vaccine 60 Nasdaq OMER biopharmaceutical 60 ZFP technology 60 OncoVEX 60 CORLUX CORT # 60 HyperAcute 60 human IgG1 monoclonal 60 candidate Zemiva TM 60 Rosetta Genomics Nasdaq ROSG 60 orthobiologic 60 please visit www.advaxis.com 60 DermaPrep 60 Kuvan R 60 visit biotech.com 60 anticancer compounds 60 Additionally Soligenix 60 refractory chronic lymphocytic 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 sd rxRNA 60 SIX RO ROG 60 CARBOSOME TM formation 60 coronary stent merged 60 Initiates Clinical Trial 60 Qualcomm Incorporated http:/www.qualcomm.com 60 ENMD # 60 ACTCellerate 60 phage display technology 60 Atripla combines 60 TÎ ² 4 60 DARA logo 60 superior ophthalmologic products 60 vascular disrupting agents 60 product platforms GVAX 60 commercialize microRNA therapeutics 60 AMEX INO 60 DG# compounds targeting 60 eligen R technology 60 product Fentanyl TAIFUN 60 developing Zerenex ferric 60 MultiCell Technologies 60 proprietary LNA 60 histone methyltransferases HMTs 60 Avila Therapeutics 60 FluoroPharma 60 oral JAK#/JAK# inhibitor 60 OTCBB CHKT 60 MPH AMEX 60 Inc. NASDAQ CRIS 60 anti CD3 monoclonal 60 TSX VIR 60 staphylococcal vaccine 60 tkRNAi technology 60 sodium Injection 60 proprietary albumin fusion 60 5 HT6 60 Inc MEDX 60 ophthalmology oncology 60 nasal powder 60 MetaDrug TM 60 Genentech Boehringer Ingelheim 60 Transdel ™ 60 novel bioadhesive drug 60 either acutely decompensated 60 INS# [001] 60 Quark Biotech 60 sulfonylhydrazine class 60 utilizes InSite Vision 60 NASDAQ CYPB 60 Cerimon Pharmaceuticals Inc. 60 CobOral oral drug 60 www.polymedix.com 60 fusion enhancers 60 Genotyping Test 60 bio therapeutics 60 predictive biomarkers 60 candidate ridaforolimus 60 Chemokine Therapeutics 60 Marqibo TM 60 Inc. Nasdaq NEXM 60 inflammatory autoimmune diseases 60 ORTHOCON 60 Hydrogen Generating System 60 MolecularBreeding 60 HSP# inhibitors 60 CyDex Pharmaceuticals Inc. 60 anti miRs antisense oligonucleotide 60 using VIAdel TM 60 signal transduction inhibitors 60 TransVax ™ 60 ribonucleotide reductase clinically validated 60 tropical parasitic 60 Inotek Pharmaceuticals Corporation 60 novel emulsion formulation 60 CMV vaccine 60 live Lm vaccines 60 Cephalon GlaxoSmithKline 60 ESPRIT therapy 60 aesthetic medicine BioLook 60 eTag assays 60 Viprovex TM 60 Viprovex R 60 DNA methylation biomarkers 60 cMET 60 PHX# 60 non personalized allogeneic 60 NASDAQ ISIS 60 maytansinoid 60 ImQuest 60 www.vioquestpharm.com 60 TriGrid 60 CollaFix ™ 60 autoimmune inflammatory 60 HydroFix TM 60 FibroGen proprietary 60 Hemopurifier ® 60 Nycomed GmbH 60 Bavarian Nordic patented 60 CollaFix TM 60 Evoltra ® 60 Ception Therapeutics 60 topically applied SEPA 60 transcutaneous immunization TCI 60 ZEVALIN ® 60 commercializing dermatological products 60 Factor VIIa 60 Bioral Amphotericin B 60 Medisorb R 60 Inc. www.micromet inc.com 60 Inc. OTCBB ALRX 60 include ClindaReach TM 60 OTCBB FCSC 60 Therapeutic Competitors companiesandmarkets.com adEgemonye 60 Kuvan sapropterin dihydrochloride 60 regenerative medicine therapies 60 APC Targeting Technology 60 Thrombin topical Recombinant 60 Predictive medicine 60 www.nanoviricides.com 60 Hedgehog agonist 60 NU# direct 60 Charlesson 60 developing Bicifadine serotonin 60 advanced pulmonary liposome 60 targeted immunotherapeutics 60 Nautilus Biotech 60 non nucleoside polymerase 60 Nasdaq MITI biopharmaceutical 60 Nasdaq HALO 60 monoclonal antibody MAb 60 indications Cytokinetics 60 tkRNAi 60 OTCBB PWRM.OB 60 Therapies SRT 60 TKM ApoB 60 BRAF kinase 60 rheumatoid arthritis thrombocytopenia 60 immunoregulation 60 Inc. Nasdaq IMGN 60 vivo fluorescence imaging 60 FUSILEV ® 60 Elan NanoCrystal 60 essential thrombocythemia ET 60 candidate TNFerade biologic 60 Enhanze 60 Romidepsin 60 NASH Huntington 60 Unit Dose Budesonide 60 PLK1 SNALP 60 include VALSTAR TM 60 AngioChem 60 Hsp# inhibition 59 EyeGate 59 CYP#A# isoenzyme 59 anti botulism antibody 59 Potelligent TM 59 commercialize Aganocide compounds 59 personalized immunotherapy 59 certain protein tyrosine 59 anti aging glycopeptides 59 Aganocide R 59 DXL TM 59 deliver innovative biomedicines 59 Pneumocystis pneumonia PCP 59 MCSP respectively 59 delay bone metastases 59 KRYSTEXXA TM pegloticase 59 www.pranabio.com 59 Receives Fast Track 59 Announces Poster Presentations 59 Nasdaq CRXL 59 CRTH2 59 RNA antagonist 59 commercializes biotherapeutics 59 AVEO integrates proprietary 59 intranasal formulation 59 Myriad logo BRACAnalysis 59 transfection reagents 59 include Healive 59 Aegis Therapeutics 59 SynCon 59 Syntonix 59 Dacetuzumab 59 recombinant subunit vaccine 59 immunotherapeutic vaccine 59 BiovaxID TM 59 antibody therapeutics 59 KAI Pharmaceuticals 59 Cobalamin ™ 59 vaccine GRNVAC1 59 Namenda Memantine HCl 59 ZFP TF 59 successfully commercialize Iluvien 59 Myolimus 59 HSP# inhibitor 59 antisense inhibitors 59 LymphoStat B TM 59 commercialize axon regeneration 59 next generation URAT1 59 metabolomics driven 59 TELINTRA 59 topical dermatological products 59 interferon alpha IFN 59 DepoVax 59 Tekmira intellectual property 59 Juvaris BioTherapeutics 59 antisense oligonucleotides 59 virosome 59 Titan proprietary ProNeura 59 immatics 59 commercializes oncology 59 investigational therapies 59 TELINTRA R 59 Anticalin R 59 Synavive ™ 59 ImmuneRegen BioSciences Inc. 59 PDE# inhibitors